Sentinel lymph node biopsy in melanoma

Current Treatment Options in Oncology

Volumn 9, Issue 4-6, 2008, Pages 243-250

  Hueman, Matthew T ^a   Lange, Julie R ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSULFAN BLUE; TECHNETIUM SULFUR COLLOID TC 99M;

CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEMATOMA; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; MELANOMA; MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SEROMA; SURGICAL INFECTION; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME; ARTICLE; INCIDENCE; LYMPH NODE; METHODOLOGY; PATHOLOGY; UNITED STATES;

HUMANS; INCIDENCE; LYMPH NODES; MELANOMA; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; UNITED STATES;

EID: 70249106786     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-008-0074-0     Document Type: Review

References (27)

1. Jemal A, Siegel R, Ward E. et al Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96 doi: 10.3322/CA.2007.0010
2. Morton DL, Thompson JF, Cochran AJ, et al. (2006) Sentinel-node Biopsy or Nodal Observation in Melanoma. New England Journal of Medicine 355(13):1307-1317 doi: 10.1056/NEJMoa060992
3. Zettersten E, Shaikh L, Ramirez R, et al Prognostic factors in primary cutaneous melanoma. Surg Clin NA 2003, 83:61-75. doi: 10.1016/ S0039-6109(02)00094-4
4. Gershenwald JE, Thomson W, Mansfield PF et al Multiinstitutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999, 17:976-83
5. Balch CM, Soong SJ, Gershenwald JE, et al Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001, 19:3622-34
6. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001, 19:3635-48
7. Dessureault S, Soong SJ, Ross MI, et al. (2001) Improved staging of node-negative patients with intermediate to thick melanomas (>1mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol 8:766-70 doi: 10.1007/s10434-001-0766-1
8. Leong SP, Kashani-Sabeet M, Desmond RA, et al Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up. World J Surg 2005, 29:683-91 doi: 10.1007/s00268-005-7736-x
9. Statius Mullet MG, Van Leeuwen PA, deLange-deKlerk ES, et al. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanoma. Cancer 2001 91: 2401-8 doi:10.1002/ 1097-0142(20010615)91:12<2401::AID-CNCR1274>3.0.CO;2-I
10. Morton DL, Wen DR, Wong JH, et al Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992, 127:392-9
11. Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Mel Res 1995, 5:255-60. doi: 10.1097/00008390-199508000-00008
12. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994, 220:759-67 doi: 10.1097/ 00000658-199412000-00009
13. Krag DN, Meijer SJ, Weaver DL, et al. Minimal access surgery for staging of malignant melanoma Arch Sirg 1995;130:654-8.
14. Leong SP, Steinmetz I, Habib FA, et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1997;132:666-72
15. Alex JC, Weaver DL, Fairbank JT, et al. Gamma probe guided lymph node localization in malignant melanoma. Surg Oncol 1993;2:303-8 doi: 10.1016/ S0960-7404(06)80006-X
16. Gershenwald JE, Tseng CH, Thompson W, et al Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabelled colloid. Surgery 1998;124:203-10
17. McMasters KM, Noyes RD, Reintgen DS, et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol 2004;86:212-23 doi: 10.1002/ jso.20084
18. Baisden, BL, Askin FB, Lange JR, et al. HMB-45 immunohistochemical staining of sentinel lymph nodes: A specific method for enhancing detection of micrometastases in patients with melanoma. Am J Surg Pathol 2000, 24:1140-6 doi: 10.1097/00000478-200008000-00012
19. Scheri RP, Essner R, Turner RR, et al. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol 2007, 14:2861-6
20. Rousseau DL, Ross MI, Johnson MM, et al. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients. Ann Surg Oncol 2003;10:569-74 doi: 10.1245/ASO.2003.09.016
21. Wong SL, Brady MS, Busam KJ, et al. Results of sentinel lymph node biopsy in patients with thin melanoma. Ann Surg Oncol 2006;13:302-9 doi: 10.1245/ASO.2006.02.021
22. Houghton AN, Coit DG, Daud A, et al. Melanoma JNCCN 2006;4:666-84.
23. Chao C, Wong SL, Ross MI, et al. Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg 2002;184: 520-4 doi: 10.1016/S0002-9610(02)01102-9
24. Vuylsteke RJ, van Leeuwen PA, Statius Muller MG, et al. Clincal outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: Long-term follow-up results. J Clin Oncol 2003, 21:1057-65 doi: 10.1200/JCO.2003.07.170
25. Wagner JD, Ranieri J, Evdokimow DZ, et al. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenecotmy for melanoma. Plast Reconstr Surg 2003;112:486-97 doi: 10.1097/01.PRS.0000070989.23469.1F
26. Zogakis TG, Essner R, Wang H, et al. Natural History of Melanoma in 773 Patients with Tumor-Negative Sentinel Lymph Nodes. Annals of Surgical Oncology, 2005;14(5):1604-1611. doi: 10.1245/s10434-006-9267-6
27. Wong SL, Morgon DL, Thompson JF, et al. Melanoma patient with positive sentinel nodes who did not undergo completion lymphadenectomy: A multiinstitutional study. Ann Surg Oncol 2006;13:809-16 doi: 10.1245/ ASO.2006.03.058